Company Profile

D2G Oncology Inc
Profile last edited on: 9/21/22      CAGE: 87FM3      UEI: CV5BLXMMLFJ3

Business Identifier: Relating drugs to genotypes to transform precision cancer therapeutics.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

353 Lowell Avenue
Palo Alto, CA 94301
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Spun out of Stanford, D2G Oncology is focused on leveraging quantitative and multiplexed functional cancer genomics to relate drugs to genotypes thereby to transform precision cancer therapeutics.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Jonathan MacQuitty -- CEO

  Sheri Haynes

  Joseph Juan -- Head of Cancer Biology | Director of Business Development

  Dmitr Petrov -- Cofounder

  Monte Winslow -- Co-Founder

  Ian Paul Winters -- Co-Founder & Director of Research

Company News

There are no news available.